Dalpicicl
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dalpicicl, covering 2025-12-16 to 2025-12-16. Get the full timeline:
Most recent: Clinical Trial Update: Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer [Phase 2]